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for the period 1991-1999. These data indicate that HlV
seroprevalence has risen dramatically from the beginning
of the surveys to 1999.
The National HIV seroprevalence rates are similar for
women attending antenatal clinics in 1998 and 1999.
This may suggest that the efforts of both Government and
civil society to prevent HIV transmission are succeeding.
It is too early, however, to draw firm conclusions from
these statistics. The point prevalence rates for these
years are associated with 95% confidence intervals
(Cls). Utilising the lower 95% Cl for 1998 and the
higher interval for 1999 suggests a continuing increase in
HIV prevalence, rather than this reaching a plateau.
Rising AIDS death rates and declining fertility among
HIV-positive women and possible changes in survey
methodology can produce variations in HIV prevalence
estimates.
Fig. 1. HIV seroprevalence in 100mell attending publicly
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The South African Department of Health <DOH) has
conducted unlinked anonymous HIV seroprevalence
surveys of women attending publicly funded antenatal
clinics since 1990.' The objectives of these surveys
include the following: Wto determine HIV prevalence in
women attending antenatal clinics; Oil to monitor trends
in HIV seraprevalence in this population over time; and
(iii) to utilise these data to estimate HIV prevalence in
the general population. The surveys utilise an unlinked
testing methodology in October of each year in order to
provide an unbiased estimate of HIV prevalence in preg-
nant women attending publicly funded antenatal clinics.
Data from these annual surveys provide the best estimate
of HIV prevalence and trends over time in South Africa.
Fig. 1 presents HIV seroprevalence data from the surveys
Major causes and determinants of
the epidemic in South Africa
Both immediate and underlying factors are contributing
to HIV transmission in South Africa. Immediate
determinants of the HIV/AIDS epidemic include behav-
ioural factors such as the frequency of unprotected sexual
intercourse and multiple sexual partners, and bio-
logical factors such as the high prevalence of sexually
transmitted diseases (STDs)' Underlying determinants
include socio-economic factors such as poverty, the
migrant labour system, the practice of commercial sex,
the low status of women, illiteracy, lack of formal edu-
cation, stigmatisation and discrimination. l
The Joint United ations Programme on HIV/ AIDS (UNAIDS) and the World Health Organisation (WHO)
have estimated that at the end of 1999 there were 33.4 million people (32.4 million adults and 1.2 million
children) infected with HIV. Approximately 96% of people with HIV / AIDS live in the developing world
and recent estimates suggest that of all people infected with HIV worldwide, 70% (6 out of every 10 men,
S of every 10 women, and 9 of every 10 children) live in sub-Saharan Africa.
It is estimated that more than 40 million people globally will be HIV-positive by the end of this year, and
still no cure has been found. The impact of the epidemic is already being felt in most developing countries,
including South Africa. Life expectancy has been significantly reduced as many people in the 15 - 49-year
age group are now dying of AIDS.
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HIV prevalence in women
attending antenatal clinics
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HIV seroprevalence data in women attending publicly
funded antenatal clinics are used to estimate HIV
prevalence in the general population. The limitations of
this survey include the inability to survey HIV prevalence
among pregnant women attending private antenatal clin-
ics; and the inability to provide HIV prevalence rates for
children, men, the elderly, those not sexually activej and
for individuals who have adopted safer sexual behaviours
that also prevent pregnancy.
As a result, HIV prevalence among women attending
antenatal clinics may overestimate the general population
prevalence for individuals under age 25 years, and under-
estimate the prevalence in people over 30. In addition,
women under 25 years attending antenatal clinics may
have a higher HIV prevalence compared with those
under 25 who may not be sexually active or who may
have adopted safer sexual practices. HIV-infected
women over 30 years old may have reduced fertility,
and so testing only women who attend antenatal clinics
could overestimate the HIV prevalence in the general
population.
It is therefore difficult to extrapolate antenatal clinic
HIV statistics to the general population, and mathe-
matical models that generate projections produce
different results depending on how the limitations of
antenatal clinic data are addressed.
Following a 1998 meeting that reviewed the various
projections available, the DD H estimated that there
would be approximately 3.9 million HIV-infected South
Africans in 1999.' Based on 1999 antenatal clinic data,
the DOH and UNAIDS now estimate that about 4.2
million South Africans are infected with HIV,' and a
recent independent report estimated that there are
currently 3.5 million HIV-infected South Africans'
According to 1999 estimates, more than 1 700 people
were infected with HIV each day, leading to a total of
more than 550 000 new infections in 1999. The DOH
estimates that 10% of the general population and 12%
of adults aged 15 - 49 years were HIV-infected in 1999,
and that by the year 2005, this will escalate to 6 million
infected South Africans, with almost 1 million children
under the age of 15 having lost their mothers to AIDS .
HIV prevalence in the general population
AIDS is currently not a notifiable disease in South Africa
and voluntary reporting seriously underestimates the
number of people with AIDS. The DOH estimates that
in 1998 there were approximately 160 000 people
living with AIDS and 120 000 AIDS deaths.' Projections
predict that by the year 2002, 250 000 South Africans
will die of AIDS each year, and that this figure will rise
to more than 1 million per year by 2008. Average life
expectancy is expected to fall from 60 years to 40 years
between 1998 and 2008.
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Fig. 2. HIV prevalence in pregnant women arrending
public antenatal clinics, by province, South Africa, 1999
(KZN - KII'aZulu-Naral; MP - Mpwnalanga:
FS - Free Srate; GP - Gaweng; NW - Nonh West;
NP . Nonhem Prol1ince; EC - Eastem Cape;
Ne - Nonhem Cape: WC - Western Cape).
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Fig. 3. HTV seropreualence in women attending antenatal
clinics, by age group, South Africa, 1999.
f.lsL..2. presents HIV prevalence data by province for
women attending antenatal clinics in 1999. These
data show that there are geographical disparities in the
distribution of the HIV/AIDS epidemic in South Africa.
In addition to differences in HIV seroprevalence between
provinces, there are also differences within provinces.
These geographical differences have persisted since the
initiation of the surveys.
fjgJ presents HIV prevalence data by age group for
women attending antenatal clinics in 1999. These data
indicate that the highest HIV seroprevalence is in women
aged 20 - 30 years, although prevalence rates are high in
all age groups. Because individuals can be HIV-positive for
several years before the development of symptoms leading
to a diagnosis of AIDS, it is estimated that more than
half of all new HIV infections in women occur in those
aged under 20 years.
The conclusions that can be reached from assessing
the data are: (j) that the HIV epidemic in South Africa
is one of the fastest growing epidemics in the world;
(iiJ that young women aged 20 - 30 years have the
highest prevalence rates; (iii) that HIV prevalence varies
by province from 7.1 % to 32.5%, with lower rates in the
Western Cape and higher rates in KwaZulu-Natal; and
(iv) that the HIV epidemic is affecting young, black, and
economically poor sub-populations of South Africa more
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Estimating the number of persons with
HIV infection and AIDS is important
for programme planning! monitoring/
and evaluation. The National HIV sero-
prevalence survey of women attending
antenatal clinics provides important
information for this purpose. There is
a need to supplement these data with
additional information in order to
characterise the HIV and AIDS epi-
demics more accuratelYI and to monitor
and evaluate current interventions. The
HIVlAIDS/STD Strategic Plan, South
Africa 2000 - 2005 describes several
objectives in this area, including: (j)
describing the incidence of new HIV
infections; <ii) determining national
changes in HIV and STD risk behaviour
(for both sexual and drug-use risk
behaviours); (iii) determining HIV
prevalence in HIV-related public health
indicators, such as clients attending
STD and TB clinics; (Iv) determining
HIV prevalence in selected general
populations; (v) describing AIDS-
related morbidity and mortality; and (vi)
developing national STD surveillance.'
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HIV/AIDS is the most important threat to the recon-
struction and development of South Africa. Best
available information indicates that in 1999 there were
approximately 3.2 - 4.2 million South Africans infected
with HIV and 160 000 people living with AI DS, with
120 000 AIDS-related deaths. The numbers of HIV-
infected South Africans and AIDS-related deaths are
expected to continue to rise over the next 5 years.
HIV/AIDS represents a significant emergency facing
South Africa. There is a need to develop additional efforts
to characterise the HIV/AIDS epidemic and to accelerate
the implementation of prevention, treatment, and care
programmes.
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STDs
Tuberculosis and HIVlAIDS
Table 1. Perce1ltage of mm aged 15 years and over ,L'lw rryorted
haring had pai'~flll un"nation or pmile discharge, genital SOT(5 or both
in the 3 nwnth5 preceding the surrey, l1y age, South Africa, 1998.
There is compelling evidence of
the importance of both ulcerative
and non-ulcerative STDs as major
determinants of HIV transmission.
Currently there is no national ST D surveillance system,
but estimates derived from the 1998 South African
Demographic and Health Survey (SADHS)' that was
based on a nationally representative sample selected
from the 1996 census data, project that there are
approximately 11 million STD episodes treated annually
in South Africa, with around 5 million of these managed
by private general practitioners. Even in the absence of
the HIV epidemic, STDs pose an important public health
problem. Table I presents data on symptoms of STDs in
men. These data indicate that almost 12% of adult men
in South Africa reported STD symptoms within the 3
months preceding the survey.
Closely linked to the HIVlAIDS
epidemic is the tuberculosis <TB)
epidemic in South Africa. HIV
increases the risk of developing
active TB for those who have been
infected with TB earlier in life. The
10% lifetime risk of developing
active TB increases to a 10% annual
risk in HIV-infected individuals. In
1998, the annual South African
incidence of TB was 283/100 000
- among the highest incidence rates
in the world. Currently about half
of all TB cases are thought to
be attributable to underlying HI V
infection. In South Africa, TB is
the most frequent cause of death
for people infected with HIV. In
some hospitals in South Africa, the
HIV prevalence rate among TB




Age group urmatIon or gemtaJ Men With Number
(yr;) discha:rge (%) sores (%) both (%) of men
15 - 24 10.4 S.6 12.1 1816
25 - 34 11.6 6.0 13.9 1 123
35 - 44 10.4 5.3 12.0 lOOS
45 - 54 9.2 5.0 10.6 701
55 - 64 10.1 2.6 10.3 518
6S+ 9.2 3.2 10.1 507
Total 10.4 5.0 11.9 5671
